Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Beta Bionics (Nasdaq: BBNX) announced a public offering of 7.65 million shares at $17.25 per share, along with pre-funded warrants, expected to raise $150 million in gross proceeds. The company plans to use the funds for commercialization of its Mint patch pump, manufacturing expansion, R&D, and clinical development. The offering is expected to close on September 17, 2026.